文献速递前列腺增生与排尿功能障碍

双极电切、钬激光剜除与绿激光汽化剜除治疗大体积BPH的3年随机试验

Randomised trial of bipolar resection vs holmium laser enucleation vs Greenlight laser vapo-enucleation of the prostate for treatment of large benign prostate obstruction: 3-years outcomes.
PubMed 文献 · BJU Int · 2020-09-30

这项随机试验比较了经尿道双极电切(TURIS)、绿激光前列腺汽化剜除(GL.PVEP)与钬激光前列腺剜除(HoLEP)治疗80-150 mL大体积BPH的3年疗效。结果显示GL.PVEP和HoLEP围手术期结局优于TURIS,但GL.PVEP手术时间更长;三种技术功能改善相当,但TURIS和GL.PVEP的3年再治疗率劣于HoLEP。

要点

  • HoLEP的3年再治疗率最低,GL.PVEP和TURIS再治疗率较高。
  • GL.PVEP手术时间最长且组织去除效率最低。
  • TURIS包膜穿孔率、住院时间、导尿时间和输血率更高。

核心结论

  • GL.PVEP和HoLEP的围手术期结局优于TURIS,但GL.PVEP手术时间显著延长。
  • 三种技术均能改善功能结局,但TURIS和GL.PVEP的3年再治疗率劣于HoLEP。

研究设计与样本

  • 随机对照试验,纳入前列腺体积80-150 mL的BPH患者,随机分入GL.PVEP、HoLEP或TURIS组。
  • 分析时纳入GL.PVEP 60例、HoLEP 60例、TURIS 62例。
  • 再治疗率的非劣效性采用单侧检验,显著性水平为5%。

主要发现

  • GL.PVEP手术时间均值(SD)为92(32)min,长于HoLEP的73(30)min和TURIS的83(28)min(P=0.005)。
  • GL.PVEP组织去除效率均值(SD)为1.2(0.4)g/min,低于HoLEP的1.7(0.7)g/min和TURIS的1.4(0.6)g/min(P<0.001)。
  • TURIS组包膜穿孔5例(8%),高于GL.PVEP组的1例(1.6%)和HoLEP组的0例(P=0.01)。
  • TURIS组住院时间、导尿时间显著更长,输血率更高。
  • 3年时,GL.PVEP组4例(6.7%)、TURIS组6例(9.7%)因复发梗阻性前列腺腺瘤再手术,HoLEP组无再手术(P=0.04)。

关键数值与推荐

  • 非劣效性检验采用单侧检验,显著性水平5%。
  • 3年再治疗率:GL.PVEP 6.7%、TURIS 9.7%、HoLEP 0%(P=0.04)。

临床怎么用

  • 对于80-150 mL大体积BPH,HoLEP在降低3年再治疗率方面可能优于GL.PVEP和TURIS。
  • GL.PVEP手术时间较长且组织去除效率较低,选择术式时需权衡。
  • TURIS围手术期并发症风险较高,尤其包膜穿孔和输血风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare transurethral resection in saline (TURIS), Greenlight laser vapo-enucleation of the prostate (GL.PVEP), and holmium laser enucleation of the prostate (HoLEP), for controlling lower urinary tract symptoms secondary to large benign prostatic hyperplasia (BPH) and to assess non-inferiority of 3-year re-treatment rates. PATIENTS AND METHODS: Eligible patients with BPH (prostate size 80-150 mL) were randomly assigned to one of the intervention groups. Non-inferiority of re-treatment rate was evaluated using a one-sided test at 5% level of significance. RESULTS: At the time of analysis, 60 GL.PVEP, 60 HoLEP and 62 TURIS procedures were included. Perioperative parameters were comparable between groups; however, the operative time was longer in GL.PVEP vs HoLEP and TURIS, at a mean (SD) of 92 (32) vs 73 (30) and 83 (28) min (P = 0.005); and was less effective with a mean (SD) removal of 1.2 (0.4) vs 1.7 (0.7) and 1.4 (0.6) g/min (P < 0.001), respectively. Perioperative complications and need for auxiliary procedures were similar in the three groups; however, there was a significantly higher rate of capsular perforation in TURIS group (five, 8%) compared to one (1.6%) in the GL.PVEP group and none in the HoLEP group (P = 0.01). There was a significantly longer hospital stay, catheter-time and higher rate of blood transfusion in the TURIS group. There was significant but comparable improvements in the International Prostate Symptom Score in three groups at different follow-up points. At 3 years, re-treatment for recurrent bladder outlet obstruction was required more after GL.PVEP and TURIS. More re-do surgeries for recurrent obstructing prostate adenoma was reported after GL.PVEP (four, 6.7%) and TURIS (six, 9.7%) than for HoLEP (none) (P = 0.04). CONCLUSION: The perioperative outcomes of GL.PVEP and HoLEP surpassed that of TURIS for the treatment of large prostates, but with a significantly prolonged operative time with GL.PVEP. The three techniques achieve good functional outcomes; however, 3-year re-treatment rates following TURIS and GL.PVEP were inferior to HoLEP.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Elshal AM, Soltan M, El-Tabey NA, et al. Randomised trial of bipolar resection vs holmium laser enucleation vs Greenlight laser vapo-enucleation of the prostate for treatment of large benign prostate obstruction: 3-years outcomes. BJU Int. 2020. PMID: 32633020. doi:10.1111/bju.15161

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。